Clinical Trial Update: Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated pirfenidone in adult patients with neurofibromatosis type 1 and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Mayo Clinic | Conditions: Neurofibromatosis | Phase 2 | Status: COMPLETED